July 11, 2025

Prognostics for Personalized Cancer Care

Meet the innovator who believes molecular profiling should be driving almost every clinical decision

The Pathologist

July 10, 2025

Apheresis Shows Promise for Removing Microplastics From Human Blood

Extracorporeal therapeutic apheresis demonstrated the ability to remove microplastic-like particles from human blood in patients with myalgic encephalomyelitis/chronic fatigue syndrome, according to a study published in Brain Medicine.

Conexiant

July 10, 2025

Mass Spec Meets Machine Learning: Decoding Sugars, Proteins, Polymers – and Mosquitoes

AI takes center stage in this week’s mass spec research roundup…

The Analytical Scientist

July 10, 2025

1 in 4 US Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 09, 2025

Recombinant Zoster Vaccine Linked to New-Onset Lupus

Researchers report the first documented case of systemic lupus erythematosus following Shingrix vaccination.

Conexiant

July 09, 2025

Oral Bacteria Linked to Brain, Gene Risk

A study of older adults found that specific oral bacteria were linked to cognitive performance and genetic risk for Alzheimer’s, while other microbes showed stronger associations in people with mild cognitive impairment.

Conexiant

July 08, 2025

Natural Cycle Beats HRT in FET Outcomes

A randomized trial found that using a natural cycle to prepare the endometrium for frozen embryo transfer in ovulatory women led to higher live birth rates and fewer complications compared to hormone replacement therapy.

Conexiant

July 08, 2025

Does Deprescribing Do More Than Less?

Deprescribing interventions reduce the number of medications taken by older adults but show no clear effect on hospitalization, mortality, or quality of life—and appear to be safe.

Conexiant

July 07, 2025

FDA Approves First Oral Hereditary Angioedema Treatment

FDA approves Ekterly (sebetralstat), the first oral on-demand treatment for hereditary angioedema, shown in trials to provide faster symptom relief and eliminate the need for injection.

Conexiant